A Population Pharmacodynamic Model for Lactate Dehydrogenase and Neuron Specific Enolase to Predict Tumor Progression in Small Cell Lung Cancer Patients

The development of individualized therapies poses a major challenge in oncology. Significant hurdles to overcome include better disease monitoring and early prediction of clinical outcome. Current clinical practice consists of using Response Evaluation Criteria in Solid Tumors (RECIST) to categorize...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Buil-Bruna, Núria, López-Picazo, José-María, Moreno-Jiménez, Marta, Martín-Algarra, Salvador, Ribba, Benjamin, Trocóniz, Iñaki F.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer US 2014
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4012048/
https://ncbi.nlm.nih.gov/pubmed/24740245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-014-9600-0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares